Top Markets
Coin of the day
Nicox S.A. Nicox S.A.

Nicox S.A.

COX
Classificação em ações #34243
Nicox S.A. is an ophthalmology enterprise operating both within France and... Nicox S.A. is an ophthalmology enterprise operating both within France and globally, focused on developing therapies to safeguard vision and enhance overall eye health. Its leading investigational drug, NCX 470, an innovative nitric oxide-donating prostaglandin analog designed to decrease intraocular pressure in individuals with open-angle glaucoma or ocular hypertension, is currently undergoing Phase 3 clinical trials. Furthermore, the company is progressing NCX 4251, a specialized fluticasone formulation, through a Phase 2b clinical trial for the management of acute exacerbations of blepharitis, as well as NCX 1728. Nicox also provides VYZULTA, a latanoprostene bunod ophthalmic solution for treating open-angle glaucoma or ocular hypertension, and ZERVIATE, a cetirizine ophthalmic solution to relieve ocular itching related to allergic conjunctivitis. The company, established in 1996, has its main office situated in Valbonne, France.
Preço da ação
$0.6379482
Última sincronização: 2023-05-22
Valor de mercado
$5.98M
Variação (1 dia)
-0.44%
Variação (1 ano)
0.00%
País
FR
Negociar Nicox S.A. (COX)

Categoria

Histórico de preços das ações de Nicox S.A. (COX)
Preço de fecho mais alto: $0.65 em 2023-05-01

Preço de fecho mais baixo: $102.25 em 2000-04-01
Histórico de preços das ações da Nicox S.A. de 2000 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2023 -48.08%
2022 -59.00%
2021 -42.67%
2020 16.87%
2019 -16.61%
2018 -54.28%
2017 42.86%
2016 -2.69%
2015 -28.86%
2014 -26.67%
2013 9.02%
2012 130.59%
2011 -56.02%
2010 -64.73%
2009 -17.78%
2008 -31.69%
2007 -41.28%
2006 626.06%
2005 -20.50%
2004 16.34%
2003 -70.85%
2002 5.93%
2001 -38.42%
2000 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE